1. Home
  2. RLAY vs PD Comparison

RLAY vs PD Comparison

Compare RLAY & PD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Relay Therapeutics Inc.

RLAY

Relay Therapeutics Inc.

HOLD

Current Price

$8.15

Market Cap

1.5B

Sector

Health Care

ML Signal

HOLD

Logo PagerDuty Inc.

PD

PagerDuty Inc.

HOLD

Current Price

$12.42

Market Cap

1.2B

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
RLAY
PD
Founded
2015
2009
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Computer Software: Prepackaged Software
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
1.5B
1.2B
IPO Year
2020
2019

Fundamental Metrics

Financial Performance
Metric
RLAY
PD
Price
$8.15
$12.42
Analyst Decision
Strong Buy
Buy
Analyst Count
7
10
Target Price
$16.00
$17.70
AVG Volume (30 Days)
2.3M
1.7M
Earning Date
11-06-2025
11-25-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
1.63
Revenue
$8,355,000.00
$489,207,000.00
Revenue This Year
$20.47
$8.16
Revenue Next Year
N/A
$3.88
P/E Ratio
N/A
$7.60
Revenue Growth
N/A
7.01
52 Week Low
$1.78
$11.13
52 Week High
$9.04
$20.00

Technical Indicators

Market Signals
Indicator
RLAY
PD
Relative Strength Index (RSI) 53.65 38.27
Support Level $8.25 $12.69
Resistance Level $8.58 $13.56
Average True Range (ATR) 0.46 0.36
MACD -0.05 0.09
Stochastic Oscillator 33.46 2.08

Price Performance

Historical Comparison
RLAY
PD

About RLAY Relay Therapeutics Inc.

Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies with the goal of bringing life-changing therapies to patients. the Dynamo platform integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-4008, RLY-2608, and GDC-1971 (formerly known as RLY-1971).

About PD PagerDuty Inc.

PagerDuty Inc is a digital operations management platform that manages urgent and mission-critical work for a modern, digital business. Its PagerDuty Operations Cloud combines artificial intelligence (AI) operations (AIOps), automation, customer service operations, and incident management with a generative AI assistant to create a flexible, resilient, and scalable platform to protect revenue and improve customer experience, improve operational efficiency, and mitigate the risk of operational failures. The company generates revenue predominantly from cloud-hosted software subscription fees and term-license software subscription fees. Geographically, the firm derives a majority of its revenue from the United States and the rest from International markets.

Share on Social Networks: